"Lilly's triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C (TRIUMPH-2, TRIUMPH-3)." Investor Relations
Patients should be cautious of unsubstantiated claims about supplements or specific foods dramatically increasing GLP-1 levels
Individuals with a Focus On Preventive Health Even if you do not have type 2 diabetes or other specific health conditions, you may still benefit from exploring GLP-1 shots from BodyLogicMD if you are interested in preventive health
PMID: 38674909
The biggest opportunity segments may not even be the most prominent users today, said John Dick, CEO and founder of consumer behaviour consultancy CivicScience
Maulucci G, Daniel B, Cohen O, Avrahami Y, Sasson S